- Answering one of the oldest questions in human physiology, researchers
at Dana-Farber have discovered why the body's immune system —
perpetually on guard against foreign microbes like bacteria — doesn't
attack tissues in the small intestine that harbor millions of bacteria
- Despite the widespread use of prescribing safeguards for infusion
chemotherapy, few of those measures have been implemented with oral
chemotherapy, according to a study led by researchers at Dana-Farber.
- Dana-Farber Cancer Institute researchers have developed a powerful
method for charting the positions of key gene-regulating molecules
called nucleosomes throughout the human genome.
Tags: Genomics, Melanoma
- A test developed by Dana-Farber scientists is the first to identify
which malignant blood cells are highly vulnerable to a promising type of
experimental drugs that unleash pent-up cell suicide factors to destroy
Tags: BasicResearch, Leukemia
- In an elegant, multiple-gene knockout experiment, a team of Boston
scientists has discovered that a trio of molecules, called FoxOs, are
fundamentally critical in preventing some cancers, maintaining blood
vessel stability, and in keeping blood-forming stem cells healthy.
- Mayor Thomas M. Menino joined Dana-Farber Cancer Institute officials on
Friday, January 26, as they celebrated the opening of their new
administrative space in the Boston Marine Industrial Park.
- Dana-Farber Cancer Institute today launched the most ambitious fundraising campaign in its history and the largest ever hospital-based campaign in New England.
- A gene whose existence was detected only a couple of years ago may
increase women's risk of breast cancer when inherited in a mutated form,
and may contribute to prostate cancer as well, researchers at
Dana-Farber and colleagues in Finland report in a new study.
Tags: BreastCancer, Genomics, Genetics
- People with advanced cancer felt they received little or no spiritual
support from religious communities and the medical system, according to a
new survey. However, those who did receive such support reported a
better quality of life.
- A study led by researchers at Dana-Farber Cancer Institute and Broad
Institute of the Massachusetts Institute of Technology and Harvard
University provides the first demonstration of a practical method of
screening tumors for cancer-related gene abnormalities that might be
treated with "targeted" drugs.
Tags: BasicResearch, Genomics, Genetics
Showing 1-10 of 518 items